Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Mast-Cell

Explore clinical trials studying Leukemia, Mast-Cell. Study availability and eligibility vary by location and protocol.

44 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Mast-Cell trial results

Completed

(EXPLORER) Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid Malignancies

NCT02561988

Conditions
Aggressive Systemic Mastocytosis, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • Stanford Cancer Institute Stanford, California, United States
  • University of Colorado Cancer Center Denver, Colorado, United States
  • Emory University Atlanta, Georgia, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Retrospective Study Assessing the Effect of Avapritinib Versus Best Available Therapy in Patients With AdvSM

NCT04695431

Conditions
Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Hematologic Diseases, +15 more
Locations
  • Standford Cancer Center Palo Alto, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Medizinische Universitat Wien Vienna, Austria
  • Universitatmedizin Mannheim Mannheim, Baden-Wurttemberg, Germany
View Trial Details
Completed

Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial

NCT00750009

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +106 more
Locations
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Fox Chase Cancer Center - Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies

NCT00014235

Conditions
Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, +159 more
Locations
  • University of Arizona Health Sciences Center Tucson, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • Stanford University Hospitals and Clinics Stanford, California, United States
  • OHSU Knight Cancer Institute Portland, Oregon, United States
View Trial Details
Completed

Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer

NCT00006251

Conditions
Acute Undifferentiated Leukemia, Adenocarcinoma, Adult Nasal Type Extranodal NK/T-cell Lymphoma, +152 more
Locations
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
  • University of Torino Torino, Italy
View Trial Details
Completed

Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia

NCT00782067

Conditions
Aberrant Motor Behavior in Dementia, Aggression, Behavior, +16 more
Locations
  • University of California at Los Angeles Dept. of Hematology Clinic Los Angeles, California, United States
  • Stanford University Medical Center Stanford University 2 Stanford, California, United States
  • Georgia Health Sciences University Dept.ofMedicalCollegeOfGeorgia Augusta, Georgia, United States
  • Dana Farber Cancer Institute Hematology / Oncology Boston, Massachusetts, United States
View all 29 locations
View Trial Details

Related conditions